effective purification of CD34 + cells had required a combination of positive and negative selection methodologies. 5,6 We and others developed methods for purifying blood To achieve a rapid and an efficient purification of CD34 + cells, we devised a nylon-fiber syringe (NF-S) and CD34 + cells, but it was difficult and time consuming to obtain CD34 + cells with a purity exceeding 90%. Other investigators reported that high purification of nificantly decreased from 22.0 ± 5.2% to 2.5 ± 0.4%, with a 73% recovery of CD34 + cells. The subsequent CD34 + cells from mobilized peripheral blood can be achieved by depleting adherent cells, such as monocytes, from immunomagnetic positive selection achieved preparations of 91 ± 8% pure CD34
Summary:
effective purification of CD34 + cells had required a combination of positive and negative selection methodologies. 5, 6 We and others developed methods for purifying blood To achieve a rapid and an efficient purification of CD34 + cells, we devised a nylon-fiber syringe (NF-S) and CD34 + cells, but it was difficult and time consuming to obtain CD34
+ cells with a purity exceeding 90%.
5-9 In we manipulated it to deplete adherent cells from normal human blood mononuclear cells (MN cells). The cells
patients undergoing autologous bone marrow (BM) or mobilized blood reinfusions, the positive selection of CD34 + processed by NF-S were further purified as the CD34 + fraction, using CD34 monoclonal antibody, immunostem/progenitor cells may also be an effective approach to rid grafts of occult malignant cells which do not express magnetic microspheres and chymopapain treatment to detach the microspheres. When steady-state human per-CD34. [10] [11] [12] [13] However, reported trials with current CD34 + selection technologies have heretofore not achieved consistipheral blood MN cells were processed by NF-S at 24؇C for 5 min, the frequency of monocytes (CD14 + cells) sigent preparations exceeding 90% pure CD34 + cells. 10, 12, 14 Other investigators reported that high purification of nificantly decreased from 22.0 ± 5.2% to 2.5 ± 0.4%, with a 73% recovery of CD34 + cells. The subsequent CD34 + cells from mobilized peripheral blood can be achieved by depleting adherent cells, such as monocytes, from immunomagnetic positive selection achieved preparations of 91 ± 8% pure CD34
+ cells with a 86 ± 23% the starting cell population. 15 In the present work, we searched for conditions for rapid depletion of monocytes, yield. The overall yield of CD34 + cells was 44 ± 11%, and the time required for all procedures was 5 h. There assessed as CD14 + cells, and a permitted frequency of residual CD14
+ cells for further purification, from normal was a tight and an inverse correlation (P Ͻ 0.0001) between the frequency of CD14 + cells in the initial cell human blood mononuclear cells. We devised a nylon-fiber syringe system for rapid and efficient CD14 + cell depletion; population and the purity of CD34 + cells in the final preparation. A recommended frequency of CD14 + cells there was an inverse correlation between the frequency of CD14 + cells in the initial cell population and the purity for achieving preparations of over 90% pure CD34 
Blood samples
CD34 is a surface glycophosphoprotein expressed on develPeripheral blood was obtained, with informed consent, opmentally early lymphohematopoietic stem and progenitor from normal adult Japanese volunteers and approximately cells, and enables the identification and purification of hem-400 ml of peripheral blood was collected in ACD-A solatopoietic progenitor cells, with use of a single reagent. [1] [2] [3] ution (ACD-A; TERUMO, Tokyo, Japan) at a final concen-CD34 + selection is used to concentrate stem cells in order tration of 13% (w/v%). to determine their characteristics and for gene therapy trials. 4 In the steady-state, in normal adult blood CD34 The MN cells in 10 ml of IMDM-BSA were transferred to and were resuspended in 10 ml of DAD-PBS. The cell susan additional 20 ml syringe (TERUMO) and gently infused pension was overlaid on 5 ml of 10% BSA in PBS containinto the NF-S, then were incubated with NF at room teming 1% ACD-A in a 15 ml conical tube (Becton-Dickinson, perature (24°C) for 0 to 30 min or at 37°C for 30 min. The Lincoln Park, NJ, USA) and was then centrifuged at 180 g MN cells were then collected into a 20 ml syringe by drawfor 10 min at 24°C to remove platelets, then this procedure ing the plunger of the syringe adjunct with positive pressure was repeated. The cells were then washed once with DADon the plunger of the NF-S, and cells were pooled in 50 ml PBS, and resuspended in 10 ml Iscove's modified Dulbecof a conical tube (collection tube; Becton Dickinson). To co's medium (IMDM; Sigma) containing 0.3% D-BSA increase the recovery of CD34 + cells, 10 ml of DAD-PBS (IMDM-BSA) (mononuclear cells; MN cells).
was reinfused into the NF-S. The cells free from NF were Platelet depletion before nylon-fiber (NF) treatment was washed three times in the NF-S by drawing or pushing the essential to prevent aggregate formation; this aggregate plunger adjunct with an inverse force on the plunger of the involves monocytes and even CD34 + cells, and there is a NF-S. The cells that did not attach to the NF were then decrease in purity and yield of the CD34 + cells. 16 The presaspirated into an additional syringe and pooled in a collecence of non-aggregated platelets also may mechanically tion tube (NF washing procedure). The NF washing prointerfere with the adhesion of CD14 + cells to NF. cedure was repeated twice, and the recovered cells were pooled in a collection tube. These pooled cells were centri-
Preparation of a nylon-fiber syringe (NF-S)
fuged at 400 g for 5 min at 4°C, and resuspended in IMDM-BSA at a concentration of 2 × 10 7 /ml (NF cells). To increase the yield of CD34 + cells and facilitate handling MN cells in a closed system, NF-S with a plunger were prepared ( Figure 1a ). Two grams of NF (Wako Pure
Purification of CD34 + cells using immunomagnetic Chemical Industries, Osaka, Japan) was packed into a 20 ml microspheres disposable syringe (TERUMO), and the plunger was set in the syringe (as for the top of gasket) to be adjusted to a
The NF cells were incubated with 2.5 g/ml QBEND10 (anti-CD34 monoclonal antibody; Seikagaku Corporation, scale of 15 ml. NF-S were sterilized by CO 2 (80 w/w%)/C 2 H 4 O (20 w/w%) gas. A three-way stopper Tokyo, Japan), which detects an epitope sensitive to chymopapain (CP). In addition, to determine an appropriate con-(Type L; TOP Chemical, Iwai, Japan), an extension tube (X1-50; TOP), and a 20 ml disposable syringe were conneccentration of QBEND10, 1 × 10 7 NF cells were incubated with QBEND10 at concentrations of 0.05, 0.25, 0.5, 2.5, 5 ted to the NF-S, and this NF-S system was attached to the standing holder, as shown in Figure 1b , just before use. and 25 g/ml in a volume of 1 ml. The recovery of CD34 + cells by immunomagnetic separation reached a plateau at a concentration of 0.5 g/ml QBEND10. In this study, therefore, a concentration of 2.5 g/ml of QBEND10 was used as a sufficient concentration to coat CD34 + cells. The CD34 + cells were purified as described elsewhere 16 with minor modifications. In brief, the cell suspension was incubated at 3°C, using an end-over-end rotator (RVM-100; Iwaki Glass, Hunabashi, Japan). After 30 min of incubation, the cells were washed twice with cold IMDM-BSA and resuspended in IMDM-BSA at a concentration of 2 × 10 7 /ml in a 12 × 75-mm polystyrene tube (Becton Dickinson).
Incubation with immunomagnetic microspheres (Dynabeads M-450 coated with goat antimouse IgG, Dynal, Great Neck, NY, USA) was done at various microspheres per cell ratio and in a range from 1:1 to 1:20, at 4°C using an end-over-end rotator. After 30 min, the cell-bound microspheres and free microspheres attached themselves to the tube wall by the magnet (Dynal MPC-1, Dynal, Fort Lee, NJ, USA), and the free cells that did not bind microspheres were removed. The tube was then disconnected from the magnet and the microspheres were washed by gentle pipetting with 3 ml of cooled IMDM- BSA. The microspheres were again attached to the tube wall using the magnet, and cells released by washing were Figure 1 Nylon-fiber syringe system (NF-S). Two grams of nylon-fiber (NF; hatched area) was packed into a 20 ml disposable syringe, and the removed (microsphere washing procedure). The plunger was set in the syringe (as for the top of a gasket) to be adjusted microsphere washing procedure was repeated twice with to a scale of 15 ml (NF-syringe; NF-S) (a). A three-way stopper, an cooled IMDM-BSA, and twice more with cooled IMDM extension tube, and an additional 20 ml disposable syringe were connected to remove BSA. The cells that bound microspheres and free to NF-S, attached to the standing holder (b), and was manipulated as described in Materials and methods.
microspheres were then gently pipetted 10 times with 2 ml of IMDM containing 130 U/ml of chymopapain cells were centrifuged at 400 g for 5 min at 4°C and resuspended in 3 ml of IMDM-BSA in a 15 × 75-mm poly-(Chymodiactin, Boots Company, Lincolnshire, IL, USA) and left for 10 min at room temperature (24°C), with 10 styrene tube. The tube was again attached to the magnet to remove contaminated microspheres, and cells free from the times pipetting every 5 min. The tube was then attached to the magnet for 2 min at 24°C. The cells released from the microspheres were collected into a 15 ml conical tube. The cells were then centrifuged at 400 g for 5 min at 4°C, microspheres were collected as the CD34 + fraction. This fraction was immediately mixed with 4.5 ml of heat-inactiand resuspended in IMDM-BSA in a small volume (approximately 0.4 ml) to count the cells (CD34 + fraction). vated fetal calf serum (FCS) (Flow Laboratories, McLean, VA, USA), at 24°C, in a 15 ml conical tube to dilute the chymopapain activity. The microspheres was washed once Flow cytometry with 3 ml of IMDM-BSA and re-attached to the magnet, and the remaining cells released from the microspheres Flow cytometry on Ortho Cytoron (Ortho Diagnostic Systems, Raritan, NJ, USA) was performed as described elsewere collected and pooled with the CD34 + fraction. The where, 17 and the data were collected with logarithmic amplification (Figure 2) 19 NF-S with 4 g NF in a Laboratories) with a 0.5 ml serum-containing fibrin clots, 50 ml barrel was feasible to manipulate 8 × 10 8 MN cells as described, 6 with 50 U/ml of recombinant human (rh) (data not shown). interleukin-3 (rIL-3; 10 8 CML U mg; Amgen Biologicals, Thousand Oaks, CA, USA), 50 U/ml of rh granulocytemacrophage colony-stimulating factor (rGM-CSF; Purification of CD34 + cells using immunomagnetic 4.5 × 10 7 U/mg; Schering Research, Bloomfield, NJ, USA), microspheres 50 U/ml of rh granulocyte-CSF (rG-CSF; 2.5 × 10 7 U/mg; Adherent cells, including CD14 + cells, may interfere with Chugai Pharmaceutical, Tokyo, Japan), 2 U/ml of rh the specific binding of immunomagnetic microspheres to erythropoietin (rEP; 180 000 U/mg; Chugai Pharma-CD34 + cells. To determine the minimum amount of ceutical). After 14 days of incubation at 37°C in a 5% microspheres required for positive selection of CD34 + cells, CO 2 /95% atmosphere, the clots were fixed and benzidine-NF cells manipulated by NF-S at 24°C for 5 min were prohematoxylin or May-Grünwald staining was done. The cessed for purification of CD34 + cells, as described in enumeration of burst forming unit-erythroid (BFU-E) and Materials and methods, then incubated with immunomagerythroid-mix was done in accordance with the criteria netic microspheres with various microsphere per cell ratios of Clarke and Housman. 18 Colonies that gave rise to in a range from 1:1 to 1:20. As shown in Table 3 , the mini-40 or more nonhemoglobinized cells were counted as nonmum microsphere per cell ratio was 1:5, which produced erythroid. a purity of CD34 + cells at 92.7 ± 3.4% with 82% recovery. Statistical significance was calculated using the t-test.
Rapid selection of human blood CD34
In these conditions, the overall recovery of CD34 + cells was 44.4 ± 11.4% with a purity of 91.2 ± 7.8% (Table 4) .
Subpopulations of purified CD34
+ cells mainly consisted of Results CD38 + cells (98.6%) and HLA-DR + cells (95.5%) ( Table  5 ). The incidence of co-expression of CD13 was about half, Characteristics of the NF-S while that of CD33, of which epitopes were suspected to be sensitive to chymopapain, was low at 2%. An appropriate temperature and incubation time were determined by incubating 1 × 10 8 MN cells with NF at As shown in Table 6 , the incidence of expression of colonies of CD34 + fractions (91.2% purity) was 19.5 ± 7.6%; room temperature (24°C) for 0-30 min, or at 37°C for 30 min (Table 1 ). Incubation at 24°C for 5 min significantly these colonies consisted of 37% of CFU-GM, 58% of BFU-E and 4% of CFU-Mix. The overall recovery of total prodecreased the frequency of CD14 + cells from 22.0 ± 5.2% (MN cells) to 2.5 ± 0.4%. No statistical difference was seen genitor cells corresponded well with that seen in CD34 + cells and was 53.9 ± 13.0% (Table 6 ). The yield of CFUin values between 5 min and 30 min regardless of whether
Rapid selection of human blood CD34
+ cells M Yamaguchi et al 377 Table 6 Recovery of hemopoietic progenitor cells through purification procedures GM was higher than those of BFU-E and CFU-Mix, but parameters. The rate of CD14 + cells for purifying CD34
Fractions Expression and recovery rates of hematopoietic progenitor cells (%) CFU-GM BFU-E CFU-Mix Total
+ cells with a purity exceeding 90% was recommended to be with no statistical significance. less than 4.4%.
Recommended rate of CD14 + cells for efficient purification of CD34
+ cells Discussion The conditions of handling NF-S to deplete CD14 + cells has been empirically determined since some experiments This is apparently the first report of a statistically verified inverse correlation between the frequency of CD14 + cells suggested that the permitted frequency of CD14 + cells is less than 5% in order to purify CD34
+ cells with a purity in the initial cell population and efficacy of purification of CD34 + cells by immunological positive selections, using exceeding 90%. This was assessed by analyzing the correlation between the frequency of CD14 + cells in the MN immunomagnetic microspheres. We also introduced a rapid method for depleting CD14 + cells, using a NF-S system. cells, NF cells, or the mixture of these cells and the purity of CD34
+ cells in CD34 + fractions (Figure 3 ). There was Compared with our previous method 6 that achieved a 94% purity of CD34
+ cells with an 8.6% recovery, the present an inverse correlation (P Ͻ 0.0001) between these two nant mature cells using microspheres and a panel of monoclonal antibodies. CD34 expression is confined to 1-4% of adult bone mar- PB-MN cells are processed on a large scale, one-step posi- 
